FMR LLC 13D and 13G filings for Seres Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-12 09:22 am Purchase | 2024-12-31 | 13G | Seres Therapeutics, Inc. MCRB | FMR LLC | 21,811,697 12.800% | 2,423,118 (+12.50%) | Filing |
| 2024-02-09 09:49 am Purchase | 2024-02-08 | 13G | Seres Therapeutics, Inc. MCRB | FMR LLC | 19,388,579 14.999% | 699,818 (+3.74%) | Filing |
| 2023-02-09 12:31 pm Purchase | 2023-02-09 | 13G | Seres Therapeutics, Inc. MCRB | FMR LLC | 18,688,761 14.999% | 4,911,691 (+35.65%) | Filing |
| 2022-02-09 10:24 am Purchase | 2022-02-08 | 13G | Seres Therapeutics, Inc. MCRB | FMR LLC | 13,777,070 14.999% | 2,440,497 (+21.53%) | Filing |
| 2021-02-08 10:33 am Purchase | 2021-02-05 | 13G | Seres Therapeutics, Inc. MCRB | FMR LLC | 11,336,573 12.423% | 536,073 (+4.96%) | Filing |
| 2020-09-10 10:03 am Purchase | 2020-09-09 | 13G | Seres Therapeutics, Inc. MCRB | FMR LLC | 10,800,500 12.095% | 4,301,382 (+66.18%) | Filing |